{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:45:53Z","timestamp":1792547153056,"version":"4.5.0"},"reference-count":41,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2025.0229","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:39:24Z","timestamp":1776767964000},"source":"Crossref","is-referenced-by-count":3,"title":["Hyperhidrosis: Prevalence, diagnosis, and stepwise treatment"],"prefix":"10.3238","author":[{"given":"Waldemar","family":"Schreiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rapprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Rzany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Wiegering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"10.3238\/arztebl.m2025.0229_ref1","doi-asserted-by":"crossref","unstructured":"Woerle B, Rapprich S, Heckmann M: Definition and treatment of primary hyperhidrosis. J Dtsch Dermatol Ges 2007; 5: 625–8.","DOI":"10.1111\/j.1610-0387.2007.06409.x"},{"key":"10.3238\/arztebl.m2025.0229_ref2","doi-asserted-by":"crossref","unstructured":"Doolittle J, Walker P, Mills T, Thurston J: Hyperhidrosis: An update on prevalence and severity in the United States. Arch Dermatol Res 2016; 308: 743–9.","DOI":"10.1007\/s00403-016-1697-9"},{"key":"10.3238\/arztebl.m2025.0229_ref3","doi-asserted-by":"crossref","unstructured":"Shayesteh A, Janlert U, Brulin C, Boman J, Nylander E: Prevalence and characteristics of hyperhidrosis in Sweden: A cross-sectional study in the general population. Dermatology 2016; 232: 586–91.","DOI":"10.1159\/000448032"},{"key":"10.3238\/arztebl.m2025.0229_ref4","doi-asserted-by":"crossref","unstructured":"Henning MAS, Barati F, Jemec GBE: Quality of life in individuals with primary hyperhidrosis: A systematic review and meta-analysis. Clin Auton Res 2023; 33: 519–28.","DOI":"10.1007\/s10286-023-00954-w"},{"key":"10.3238\/arztebl.m2025.0229_ref5","doi-asserted-by":"crossref","unstructured":"Kisielnicka A, Szczerkowska-Dobosz A, Purzycka-Bohdan D, Nowicki RJ: Hyperhidrosis: Disease aetiology, classification and management in the light of modern treatment modalities. Postepy Dermatol Alergol 2022; 39: 251–7.","DOI":"10.5114\/ada.2022.115887"},{"key":"10.3238\/arztebl.m2025.0229_ref6","unstructured":"Schlereth T, Dieterich M, Birklein F: Hyperhidrosis—cases and treatment of enhanced sweating. Dtsch Aerztbl Int 2009; 106: 32–7."},{"key":"10.3238\/arztebl.m2025.0229_ref7","doi-asserted-by":"crossref","unstructured":"Kristensen JK, Nielsen C: Progress and lack of progress in hyperhidrosis research 2015–2020. A concise systematic review. Int J Dermatol 2022; 61: 148–57.","DOI":"10.1111\/ijd.15654"},{"key":"10.3238\/arztebl.m2025.0229_ref8","doi-asserted-by":"crossref","unstructured":"Solish N, Bertucci V, Dansereau A, et al.: A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg 2007; 33: 908–23.","DOI":"10.1111\/j.1524-4725.2007.33192.x"},{"key":"10.3238\/arztebl.m2025.0229_ref9","unstructured":"Rzany B, Bechara F, Feise K, et al.: S1-Leitlinie Definition und Therapie der prim\u00e4ren Hyperhidrose. AWMF-Register-Nr.: 013–059, 2023 www.register.awmf.org\/de\/leitlinien\/detail\/013–059."},{"key":"10.3238\/arztebl.m2025.0229_ref10","doi-asserted-by":"crossref","unstructured":"Schick C: Pathophysiology of hyperhidrosis. Thorac Surg Clin 2016; 26: 389–99.","DOI":"10.1016\/j.thorsurg.2016.06.002"},{"key":"10.3238\/arztebl.m2025.0229_ref11","doi-asserted-by":"crossref","unstructured":"Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–6.","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"10.3238\/arztebl.m2025.0229_ref12","doi-asserted-by":"crossref","unstructured":"Kamudoni P, Mueller B, Salek MS: The development and validation of a disease-specific quality of life measure in hyperhidrosis: The Hyperhidrosis Quality of Life Index (HidroQOL). Qual Life Res 2015; 24: 1017–27.","DOI":"10.1007\/s11136-014-0825-2"},{"key":"10.3238\/arztebl.m2025.0229_ref13","unstructured":"Bundesinstitut f\u00fcr Risikobewertung: Neue Studien zu aluminiumhaltigen Antitranspirantien: Gesundheitliche Beeintr\u00e4chtigungen durch Aluminium-Aufnahme \u00fcber die Haut sind unwahrscheinlich. www.bfr.bund.de\/cm\/343\/neue-studien-zu-aluminiumhaltigen-antitranspirantien-gesundheitliche-beeintr\u00e4chtigungen-durch-aluminium-aufnahme-ueber-die-haut-sind-unwahrscheinlich.pdf (last accessed on 27 September 2025)."},{"key":"10.3238\/arztebl.m2025.0229_ref14","doi-asserted-by":"crossref","unstructured":"Hoelzle E: Topical pharmacological treatment. Curr Probl Dermatol 2002; 30: 30–43.","DOI":"10.1159\/000060693"},{"key":"10.3238\/arztebl.m2025.0229_ref15","doi-asserted-by":"crossref","unstructured":"Attallah HS, El-Gilany AH, Youssef YEB, Abdelshaheed ME, Sharaf EFA: Efficacy, safety and quality of life of oxybutynin versus aluminum chloride hexahydrate in treating primary palmar hyperhidrosis. Indian J Dermatol 2022; 67: 222–7.","DOI":"10.4103\/ijd.IJD_799_20"},{"key":"10.3238\/arztebl.m2025.0229_ref16","doi-asserted-by":"crossref","unstructured":"Lamb Y: Topical glocopyrronium tosylate in primary axillary hyperhidrosi: A profile of its use. Clin Drug Investing 2019; 39: 1141–7.","DOI":"10.1007\/s40261-019-00853-x"},{"key":"10.3238\/arztebl.m2025.0229_ref17","doi-asserted-by":"crossref","unstructured":"Glaser DA, Hebert AA, Nast A, et al.: Topical glycopyrronium tosylate for the treatment of primary axillaryhyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials. J Am Acad Dermatol 2019; 80: 128–38.","DOI":"10.1016\/j.jaad.2018.07.002"},{"key":"10.3238\/arztebl.m2025.0229_ref18","doi-asserted-by":"crossref","unstructured":"Herbert AA, Glaser DA, Green L, et al.: Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials. Pediatric Dermatology 2019; 36: 89–9.","DOI":"10.1111\/pde.13723"},{"key":"10.3238\/arztebl.m2025.0229_ref19","doi-asserted-by":"crossref","unstructured":"Artzi O, Loizides C, Zur E, Sprecher E: Topical oxybutynin 10 % gel for the treatment of primary focal hyperhidrosis: A randomized double-blind placebo-controlled split area study. Acta Term Venereol 2017; 97: 1120–4.","DOI":"10.2340\/00015555-2731"},{"key":"10.3238\/arztebl.m2025.0229_ref20","doi-asserted-by":"crossref","unstructured":"El-Samadony AE, Hegab DS, El Maghraby GM, El-Maadawy IH: Topical oxybutynin 3 % gel versus aluminum chloride 15 % lotion in treatment of primary focal hyperhidrosis. Dermatol Pract Concept 2023; 13: e2023192.","DOI":"10.5826\/dpc.1303a192"},{"key":"10.3238\/arztebl.m2025.0229_ref21","doi-asserted-by":"crossref","unstructured":"Kim DH, Kim TH, Lee SH, Lee AY: Treatment of palmar hyperhidrosis with tap water Iontophoresis: A randomized, sham-controlled, single-blind, and parallel-designed clinical trial. Ann Dermatol 2017; 29: 728–34.","DOI":"10.5021\/ad.2017.29.6.728"},{"key":"10.3238\/arztebl.m2025.0229_ref22","doi-asserted-by":"crossref","unstructured":"Castiglione L, Murariu M, Boeriu E, Enatescu I: Assessing botulinum toxin effectiveness and quality of life in axillary hyperhidrosis: A one-year prospective study. Diseases 2024; 12: 15.","DOI":"10.3390\/diseases12010015"},{"key":"10.3238\/arztebl.m2025.0229_ref23","doi-asserted-by":"crossref","unstructured":"Farrell J, Stewart T, Singh B, Singh G, Rosen R: Retrospective analysis of the efficacy and duration of botulinum toxin A injections in 30 patients with palmar hyperhidrosis. Intern Med J 2021; 51: 1517–21.","DOI":"10.1111\/imj.15489"},{"key":"10.3238\/arztebl.m2025.0229_ref24","doi-asserted-by":"crossref","unstructured":"Hashimoto FN, Cataneo DC, Hashimoto EN, Ximenez AMG, Cataneo AJM: Radiofrequency in the treatment of primary hyperhidrosis: Systematic review and meta-analysis. Clin Auton Res 2020; 30: 11–120.","DOI":"10.1007\/s10286-019-00640-w"},{"key":"10.3238\/arztebl.m2025.0229_ref25","doi-asserted-by":"crossref","unstructured":"Naeini FF, Abtahi-Naeini B, Pourazizi M, et al.: Fractionated microneedle radiofrequency for treatment of primary axillary hyperhidrosis: A sham control study: Radiofrequency for treatment of PAH. Australas J Dermatol 2015; 56: 279–84.","DOI":"10.1111\/ajd.12260"},{"key":"10.3238\/arztebl.m2025.0229_ref26","doi-asserted-by":"crossref","unstructured":"Abtahi-Naeini B, Naeini FF, Saffaei A, et al.: Treatment of primary axillary hyperhidrosis by fractional microneedle radiofrequency: Is it still effective after long-term follow-up? Indian J Dermatol 2016; 61: 234.","DOI":"10.4103\/0019-5154.177789"},{"key":"10.3238\/arztebl.m2025.0229_ref27","unstructured":"Nestor MS, Park H: Safety and efficacy of micro-focused ultrasound plus visualization for the treatment of axillary hyperhidrosis. J Clin Aesthet Dermatol 2014; 7: 14–21."},{"key":"10.3238\/arztebl.m2025.0229_ref28","doi-asserted-by":"crossref","unstructured":"Hong HC, Lupin M, O`Shaughnessy KF: Clinical evaluation of a microwave device for treating axillary hyperhidrosis. Dermatol Surg 2012; 38: 728–35.","DOI":"10.1111\/j.1524-4725.2012.02375.x"},{"key":"10.3238\/arztebl.m2025.0229_ref29","doi-asserted-by":"crossref","unstructured":"Suh Dh, Lee SJ, Kim K, Ryu HJ: Transient median and ulnar neuropathy associated with a microwave device for treating axillary hyperhidrosis. Dermatol Surg 2014; 40: 482–5.","DOI":"10.1111\/dsu.12425"},{"key":"10.3238\/arztebl.m2025.0229_ref30","doi-asserted-by":"crossref","unstructured":"Bechara FG: Hyperhidrosis—causes and treatment of enhanced sweating: Surgical treatment of focal hyperhidrosis. Dtsch Arztebl Int 2009; 106: 448.","DOI":"10.3238\/arztebl.2009.0448a"},{"key":"10.3238\/arztebl.m2025.0229_ref31","doi-asserted-by":"crossref","unstructured":"Wollina U, K\u00f6stler E, Schr\u00f6nlebe J, et al.: Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis. Dermatol Surg 2008; 34: 709–16.","DOI":"10.1111\/j.1524-4725.2008.34132.x"},{"key":"10.3238\/arztebl.m2025.0229_ref32","doi-asserted-by":"crossref","unstructured":"Ibrahim O, Kakar R, Bolotin D, et al.: The comparative effectiveness of suction-curettage and hnabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: A randomized control trial. J Am Acad Dermatol 2013; 69: 88–95.","DOI":"10.1016\/j.jaad.2013.02.013"},{"key":"10.3238\/arztebl.m2025.0229_ref33","doi-asserted-by":"crossref","unstructured":"Cerfolio RJ, De Campos JR, Bryant AS, et al.: The society of thoracic surgeons expert consensus for the surgical treatment of hyperhidrosis. Ann Thorac Surg 2011; 91: 1642–8.","DOI":"10.1016\/j.athoracsur.2011.01.105"},{"key":"10.3238\/arztebl.m2025.0229_ref34","doi-asserted-by":"crossref","unstructured":"Wolosker N, de Campos JRM, Kauffman P, et al.: Cohort study on 20 years‘ experience of bilateral video-assisted thoracic sympathectomy (VATS) for treatment of hyperhidrosis in 2431 patients. Sao Paulo Med J 2022; 140: 284–9.","DOI":"10.1590\/1516-3180.2021.0078.r1.23072021"},{"key":"10.3238\/arztebl.m2025.0229_ref35","doi-asserted-by":"crossref","unstructured":"Schreiner W, Mykoliuk I, Dudek W, Sirbu H: Bedeutung der selektiven Lebensqualit\u00e4tsanalyse nach Sympathikus-Clipping bei Patienten mit lokaler Hyperhidrose. Zentralbl Chir 2019; 144: 139–45.","DOI":"10.1055\/a-0808-5003"},{"key":"10.3238\/arztebl.m2025.0229_ref36","doi-asserted-by":"crossref","unstructured":"O`Connor K, Molin F, Poirer P, Vaillancourt R: Cardiac arrest as a major complication of bilateral cervico-dorsal sympathectomy. Interact Cardiovasc Thorac Surg 2009; 8: 238–9.","DOI":"10.1510\/icvts.2008.188011"},{"key":"10.3238\/arztebl.m2025.0229_ref37","doi-asserted-by":"crossref","unstructured":"Hur KJ, Moon HW, Park YH, et al.: Retroperitoneoscopic lumbal sympathectomy for the treatment of primary plantar hyperhidrosis. BMC Surg 2021; 21: 397.","DOI":"10.1186\/s12893-021-01393-y"},{"key":"10.3238\/arztebl.m2025.0229_ref38","doi-asserted-by":"crossref","unstructured":"Hund M, Sinkgraven R, Rzany B: Randomisierte, plazebo-kontrollierte Doppelblindstudie zur Wirksamkeitsbewertung und Sicherheit von Methantheliniumbromide (Vagantin) zur Behandlung der fokalen Hyperhidrose. J Dtsch Dermatol Ges 2004; 2: 343–34.","DOI":"10.1046\/j.1439-0353.2004.04765.x"},{"key":"10.3238\/arztebl.m2025.0229_ref39","doi-asserted-by":"crossref","unstructured":"Campanati A, Gregoriou S, Kontochristopoulos G, Offidani A: Oxybutynin for treatment of primary hyperhidrosis: urrent state of the art. Skin Appendage Disord 2015; 1: 6–13.","DOI":"10.1159\/000371581"},{"key":"10.3238\/arztebl.m2025.0229_ref40","doi-asserted-by":"crossref","unstructured":"Schollhammer M, Brenaut E, Menard-Andivot N, et al.: Oxybutynin as a treatment for generalized hyperhidrosis: A randomized, placebo-controlled trial. Br J Dermatol 2015; 173: 1163–8.","DOI":"10.1111\/bjd.13973"},{"key":"10.3238\/arztebl.m2025.0229_ref41","unstructured":"McConaghy JR, Fosselman D: Hyperhidrosis: Management options. Am Fam Physician 2018; 97: 729–34."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:40:24Z","timestamp":1776768024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":41,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2025.0229","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}